Welcome to Jeopardy! New Drugs of 2012 Brand/ Generic Indication Whats New? Potpourri Mechanism.
XDR-TB Extensively Drug-Resistant Tuberculosis What, Where, How and Action Steps…
Global Medical Cures™ | Antibiotics Resistance Threats in USA
Linezolid for treatment of chronic XDR journal presentation
Adverse Reactions TB Therapy
CORPORATE OVERVIEW TNIB is a late stage immunotherapy company with short term sustainable revenue delivering low cost, effective, safe immuno therapies.
ANTIMICROBIAL THERAPY CHAPTER 13 Copyright © 2012 John Wiley & Sons, Inc. All rights reserved.
Mycobacterial Infections Robert F. Nash D.O. 2007.
A decentralized model of care for drug-resistant tuberculosis in a high HIV prevalence setting Cheryl McDermid, Helen Cox, Simiso Sokhela, Gilles van Cutsem,
Tuberculosis burden in households of patients with multi drug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort study.
Tuberculosis Infection Control
What do case-control studies tell us about risk factors for antibiotic resistance?
